AACP
Advantage Alpha Capital Partners Portfolio holdings
AUM
$371M
This Quarter Return
+14.19%
1 Year Return
+16.18%
3 Year Return
+64.49%
5 Year Return
+102.68%
10 Year Return
–
AUM
$528M
AUM Growth
+$528M
(+11%)
Cap. Flow
+$4.48M
Cap. Flow
% of AUM
0.85%
Top 10 Holdings %
Top 10 Hldgs %
20.16%
Holding
167
New
74
Increased
51
Reduced
29
Closed
13
Top Buys
| 1 |
Magnite
MGNI
|
$4.72M |
| 2 |
HubSpot
HUBS
|
$4.44M |
| 3 |
BCPC
Balchem Corporation
BCPC
|
$4.41M |
| 4 |
Interparfums
IPAR
|
$4.15M |
| 5 |
Knife River
KNF
|
$4.11M |
Top Sells
| 1 |
NATI
National Instruments Corp
NATI
|
$9.64M |
| 2 |
RB Global
RBA
|
$8.56M |
| 3 |
LPL Financial
LPLA
|
$8.45M |
| 4 |
Construction Partners
ROAD
|
$5.94M |
| 5 |
Planet Fitness
PLNT
|
$5.37M |
Sector Composition
| 1 | Industrials | 30.14% |
| 2 | Technology | 20.35% |
| 3 | Financials | 12.43% |
| 4 | Consumer Discretionary | 10.63% |
| 5 | Healthcare | 10.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Helen of Troy
HELE
$605M
| $2.81M | 0.53% |
23,235
+3,684
| +19% | +$445K |
|
77
Upwork
UPWK
$2.19B
| $2.74M | 0.52% |
184,401
+4,913
| +3% | +$73.1K |
|
78
Paymentus
PAY
$4.7B
| $2.6M | 0.49% |
145,564
-77,256
| -35% | -$1.38M |
|
79
TriNet
TNET
$3.46B
| $2.56M | 0.49% |
21,558
-12,638
| -37% | -$1.5M |
|
80
Procore
PCOR
$10.2B
| $2.53M | 0.48% |
36,573
-509
| -1% | -$35.2K |
|
81
Omnicell
OMCL
$1.5B
| $2.47M | 0.47% |
65,525
+1,416
| +2% | +$53.3K |
|
82
HealthEquity
HQY
$8.13B
| $2.36M | 0.45% |
35,524
-60,777
| -63% | -$4.03M |
|
83
Boot Barn
BOOT
$5.48B
| $2.1M | 0.4% |
27,409
+580
| +2% | +$44.5K |
|
84
Leslie's
LESL
$61.3M
| $2.02M | 0.38% |
291,777
-130,963
| -31% | -$905K |
|
85
Helios Technologies
HLIO
$1.74B
| $1.9M | 0.36% |
41,950
+867
| +2% | +$39.3K |
|
86
Arcturus Therapeutics
ARCT
$465M
| $1.59M | 0.3% |
+50,524
| New | +$1.59M |
|
87
Entrada Therapeutics
TRDA
$202M
| $1.59M | 0.3% |
+105,137
| New | +$1.59M |
|
88
Voyager Therapeutics
VYGR
$208M
| $1.49M | 0.28% |
+176,871
| New | +$1.49M |
|
89
Ironwood Pharmaceuticals
IRWD
$190M
| $1.44M | 0.27% |
+125,705
| New | +$1.44M |
|
90
Vanda Pharmaceuticals
VNDA
$278M
| $1.43M | 0.27% |
+339,333
| New | +$1.43M |
|
91
Zymeworks
ZYME
$1.06B
| $1.42M | 0.27% |
+136,819
| New | +$1.42M |
|
92
MiMedx Group
MDXG
$1.04B
| $1.38M | 0.26% |
+157,705
| New | +$1.38M |
|
93
Alkermes
ALKS
$4.96B
| $1.37M | 0.26% |
+49,530
| New | +$1.37M |
|
94
Veracyte
VCYT
$2.39B
| $1.27M | 0.24% |
+46,125
| New | +$1.27M |
|
95
Arcellx
ACLX
$3.89B
| $1.26M | 0.24% |
+22,673
| New | +$1.26M |
|
96
Latham Group
SWIM
$907M
| $1.25M | 0.24% |
474,747
+10,220
| +2% | +$26.9K |
|
97
Dynavax Technologies
DVAX
$1.18B
| $1.25M | 0.24% |
+89,087
| New | +$1.25M |
|
98
Vericel Corp
VCEL
$1.71B
| $1.21M | 0.23% |
+33,876
| New | +$1.21M |
|
99
Halozyme
HALO
$8.7B
| $1.11M | 0.21% |
+29,917
| New | +$1.11M |
|
100
International Bancshares
IBOC
$4.41B
| $572K | 0.11% |
+10,535
| New | +$572K |
|